The principle of therapeutic nucleic acid repair has been demonstrated
in cell-free and cell culture experiments, in which compounds bind to
and repair mutated sequences, thereby treating the primary defects of
genetic disease. The mechanisms used to promote repair are diverse, e
ncompassing techniques related to antisense,triple-strand, and ribozym
es. Therapeutic nucleic acid repair has the potential to revert mutati
ons to wild type, and therefore is more suitable than traditional gene
therapy for treating gain-of-function mutations.